MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-19-2026
Guardant Health ROA Ratio 2011-2026 | GH
Annual ROA Ratio Guardant Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -20.67 | -29.37 | -26.84 | -40.66 | -17.45 | -10.84 | -7.86 | -14.48 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -7.86 | -40.66 | -21.02 |
Quarterly ROA Ratio Guardant Health
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -28.58 | -27.46 | -20.13 | -24.92 | -22.7 | -20.28 | -17.58 | -27.1 | -31.83 | -33.66 | -21.09 | -25.92 | -15.45 | -19.71 | -13.66 | -16.82 | -15.14 | -13.07 | -6.75 | -8.11 | -6.31 | -5.29 | -4.75 | -8.92 | -11.72 | -14.23 | -10.2 | -18.54 | -22.71 | -19.03 | -8.34 | -8.34 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -4.75 | -33.66 | -17.14 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Castle Biosciences
CSTL
|
-4.18 | $ 22.01 | -11.09 % | $ 638 M |  USA |
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 17.01 | - | $ 179 M |  China |
 |
Agilent Technologies
A
|
11.3 | $ 118.28 | 0.43 % | $ 36 B | USA |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-234.24 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
-5.17 | $ 21.69 | 3.53 % | $ 1.16 B | USA |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Co-Diagnostics
CODX
|
-189.54 | $ 1.65 | 0.61 % | $ 2.19 M | USA |
 |
Medpace Holdings
MEDP
|
22.84 | $ 428.82 | 0.48 % | $ 12.4 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
-2.02 | $ 187.3 | 3.06 % | $ 9.28 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
Myriad Genetics
MYGN
|
-51.8 | $ 4.17 | 1.34 % | $ 386 M | USA |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
-7.94 | $ 8.99 | 1.07 % | $ 1.15 B | USA |
 |
National Research Corporation
NRC
|
8.6 | $ 18.09 | 1.26 % | $ 405 M | USA |
 |
Natera
NTRA
|
-39.28 | $ 216.86 | 0.82 % | $ 21.3 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-3.55 | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 14.8 | -0.8 % | $ 447 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
3.33 | $ 27.58 | 1.4 % | $ 26.2 B |  Niderland |
 |
Personalis
PSNL
|
-30.08 | $ 6.12 | 0.82 % | $ 363 M | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 124.97 | 0.68 % | $ 10.3 B |  Irlanda |
 |
Illumina
ILMN
|
-19.4 | $ 138.93 | -2.56 % | $ 22.1 B | USA |
 |
Soleno Therapeutics
SLNO
|
3.71 | $ 52.94 | -0.01 % | $ 2.69 B | USA |
 |
Senseonics Holdings
SENS
|
-54.73 | $ 5.3 | -1.12 % | $ 221 M | USA |
 |
Interpace Biosciences
IDXG
|
72.63 | $ 2.04 | -3.33 % | $ 9.02 M | USA |
 |
QIAGEN N.V.
QGEN
|
6.76 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
-83.65 | $ 2.19 | -0.9 % | $ 5.03 M | USA |
 |
Thermo Fisher Scientific
TMO
|
6.08 | $ 472.26 | -0.23 % | $ 178 B | USA |
 |
Lantheus Holdings
LNTH
|
10.49 | $ 90.2 | 4.7 % | $ 6.09 B | USA |
 |
Trinity Biotech plc
TRIB
|
-30.22 | $ 0.61 | 1.72 % | $ 219 M | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
4.77 | $ 256.45 | -0.19 % | $ 21.3 B | USA |
 |
Celcuity
CELC
|
-37.95 | $ 132.46 | -5.01 % | $ 6.19 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
-12.1 | $ 59.1 | -0.72 % | $ 3.53 B | USA |
 |
Neogen Corporation
NEOG
|
-31.71 | $ 9.14 | -0.44 % | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
6.11 | $ 188.42 | -0.38 % | $ 20.9 B | USA |
 |
Invitae Corporation
NVTA
|
-5.11 | - | - | $ 21.2 M | USA |